{"id":"W4288080559","doi":"10.1111/all.15456","title":"Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma","year":2022,"lang":"en","type":"article","venue":"Allergy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Sanofi Genzyme; Genentech; Grifols; AstraZeneca; Chiesi Farmaceutici; CSL Behring; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Patient-Centered Outcomes Research Institute; National Institutes of Health; Allergy Therapeutics; Shionogi; Sanofi; Mereo BioPharma; Vifor Pharma; Pfizer; Amgen","keywords":"Dupilumab; Medicine; Lung function; Asthma; Asthma exacerbations; Severity of illness; Lung; Intensive care medicine; Immunology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004033206,0.0001183427,0.0001843434,0.0001680775,0.0000930844,0.000004978017,0.00005198921,0.00003245166,0.001150083],"category_scores_gemma":[0.00002749596,0.00009217677,0.00005897479,0.0003884853,0.00001403307,0.00005400366,0.000038335,0.0001313865,0.00001167736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002213562,"about_ca_system_score_gemma":0.0002716876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008026746,"about_ca_topic_score_gemma":0.00002292175,"domain_scores_codex":[0.9990953,0.00005978767,0.0001670973,0.0002048093,0.0003121455,0.0001608488],"domain_scores_gemma":[0.9994646,0.00001815935,0.00006276948,0.0002228899,0.0001159915,0.0001156336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.05796583,0.004878946,0.4308192,0.0001009755,0.0008153129,0.00006899501,0.001381457,0.4402122,0.001208611,0.0002986691,0.04568167,0.01656813],"study_design_scores_gemma":[0.003331101,0.005303876,0.9879144,0.00005133082,0.00001794359,0.000003691072,0.0001335644,0.0005004149,0.0000260721,0.0000121057,0.002573283,0.0001322595],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976936,0.00006067523,0.000008777242,0.00007434044,0.00009370678,0.0003411257,0.00003623699,0.00002388027,0.001667674],"genre_scores_gemma":[0.9987489,0.00000221255,0.00002357317,0.0002433168,0.00003376245,0.00003669255,0.0001619045,0.00002393768,0.0007257138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5570951,"threshold_uncertainty_score":0.999763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008425355632608916,"score_gpt":0.2486449790773829,"score_spread":0.240219623444774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}